Filing Details
- Accession Number:
- 0001179110-20-001909
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-19 18:42:36
- Reporting Period:
- 2020-02-14
- Accepted Time:
- 2020-02-19 18:42:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1229450 | A Craig Wheeler | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-14 | 21,894 | $13.26 | 39,372 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-14 | 21,894 | $32.00 | 17,478 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-02-14 | 21,894 | $0.00 | 21,894 | $13.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-11-22 | 2021-02-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 36,725 | Indirect | Craig A Wheeler 2016 Annuity Trust |
Common Stock | 48,263 | Indirect | Craig A Wheeler 2018 Annuity Trust |
Common Stock | 419,934 | Indirect | Craig Wheeler Revocable Trust |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.
- This transaction was executed in multiple trades at prices ranging from $32.00 to $32.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.